Can AI help find the cure for cancer?

December 20, 2023

Cancer is a leading natural cause of death for humans worldwide, second only to heart disease. Cancer is a complex group of diseases characterized by the uncontrolled and abnormal growth of cells in the body. In a healthy body, cells grow, divide, and die in a controlled manner as part of the natural process of tissue renewal and repair. Cancer disrupts that natural process, leading to the formation of a mass or lump of tissue called a tumor. These abnormal cells forming the tumor can continue to divide and grow, often invading surrounding tissues and potentially spreading to other parts of the body through a process known as metastasis.

Here are some key characteristics of cancer:

• Uncontrolled Cell Growth: Cancer begins when genetic mutations or changes in the DNA of a cell disrupt the mechanisms that regulate cell growth and division. Mutated cells evade the body's natural checks and balances, leading to uncontrolled proliferation.
• Tumors. The accumulation of abnormal cells forms a lump or mass called a tumor. Tumors can be benign (noncancerous) or malignant (cancerous). Benign tumors do not invade surrounding tissues or spread to other parts of the body. They are typically slow-growing and are usually not life-threatening, although they can cause health problems depending on their location and size. Malignant tumors have the ability to invade nearby tissues and may spread to other parts of the body through the bloodstream or lymphatic system. These tumors are cancerous and can be life-threatening.
• Metastasis: Metastasis is the process by which cancer cells break away from the primary tumor, enter the bloodstream or lymphatic vessels, and travel to distant organs or tissues, where they can form secondary tumors. Metastasis is a key factor in the severity and progression of cancer.
• Heterogeneity: Cancer is not a single disease but a collection of diverse diseases that can affect different organs and tissues. Each type of cancer may have unique characteristics and behaviors, making it challenging to develop a one-size-fits-all treatment.
• Risk Factors: Various factors can increase the risk of developing cancer, including genetic predisposition, exposure to carcinogens (cancer-causing agents), lifestyle choices (such as smoking and diet), environmental factors, infections, and hormonal imbalances.
• Symptoms: The symptoms of cancer vary widely depending on its type, location, and stage. Common symptoms may include fatigue, unexplained weight loss, pain, changes in the skin or moles, persistent cough or hoarseness, and other signs that prompt medical evaluation.
• Diagnosis and Treatment: The diagnosis of cancer typically involves a combination of methods, including medical imaging (such as X-rays and scans), biopsies, and laboratory tests. Treatment options for cancer include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, hormone therapy, and palliative care, among others. The choice of treatment depends on the type and stage of cancer, as well as the individual's health and preferences.

Advances in cancer research and treatment have led to improved outcomes for many individuals. According to Our World in Data, about 10 million humans die from cancer every year. This is about one in six deaths and makes cancer one of the world's biggest health problems. Cancer can kill when it invades essential organs, like liver, lungs, or brain, and stops them from functioning properly. These complications could be due to primary cancer that starts in an essential organ, such as brain cancer, or it could be cancer that has metastasized from one area of the body to another. According to Cancer.Net, about 18% of cancer survivors have survived 20 years or more after diagnosis, with 64% of survivors being 65 or older. Early detection, prevention efforts, and ongoing research are crucial in the fight against cancer. Additionally, lifestyle choices, such as maintaining a healthy diet, regular exercise, avoiding tobacco, and protecting against exposure to carcinogens, can reduce the risk of developing cancer.

Interestingly, some animals seem resistant to cancer and rarely develop tumors. These include some large mammals like whales and elephants; some subterranean mammals like naked mole rats and blind mole rats; other mammals like horses, cows, bats, and squirrels. Herbivorous mammals have lower rates of cancer than carnivores. The incidence of cancer in non-human primates is very low, especially for epithelial neoplasms like breast, prostate, and lung carcinomas. Scientists call this Peto's paradox: cancer is caused by gene mutations that accumulate in cells over time, yet long-lived animals with lots of cells rarely get it. For example, elephants have 40 alleles from twenty p53 genes, each slightly different from the others. This gives elephants a wider range of molecular anti-cancer interactions than humans, who have just two alleles from a single gene. However, elephants rarely get cancer.

Human Brain Cancer

A brain tumor is an abnormal growth or mass of cells within the brain or the central nervous system (CNS). These tumors can develop from different types of cells within the brain, including neurons (nerve cells), glial cells (supporting cells), and other cell types. Brain tumors can be benign (noncancerous) or malignant (cancerous), and they can originate within the brain itself (primary brain tumors) or spread to the brain from other parts of the body (metastatic or secondary brain tumors).

• Primary Brain Tumors: These tumors originate within the brain or the surrounding tissues of the CNS. Primary brain tumors can be either benign or malignant. They are often classified based on the type of cells from which they originate, such as gliomas (arising from glial cells), meningiomas (from the meninges or membranes covering the brain), and others.
• Malignant Brain Tumors: Malignant brain tumors, also known as brain cancer, are more aggressive and can invade nearby healthy brain tissue. They can also spread to other parts of the CNS. Common examples of malignant brain tumors include glioblastoma multiforme (a highly aggressive glioma) and anaplastic astrocytoma.
• Benign Brain Tumors: Benign brain tumors are noncancerous and tend to grow more slowly than malignant tumors. They typically do not invade surrounding brain tissue. However, depending on their size and location, benign tumors can still cause symptoms and health issues. An example of a benign brain tumor is a meningioma.
• Metastatic Brain Tumors (Secondary Brain Tumors): Metastatic brain tumors occur when cancer cells from other parts of the body (such as the lung, breast, or skin) spread to the brain through the bloodstream or lymphatic system. These tumors are considered secondary to the primary cancer.

Brain tumors can cause a wide range of symptoms, including headaches, seizures, cognitive changes, weakness, difficulty with balance and coordination, vision problems, and personality changes. The specific symptoms can vary depending on the tumor's size, location, and impact on surrounding brain functions.

Diagnosis typically involves medical imaging techniques such as MRI (magnetic resonance imaging) and CT (computed tomography) scans, as well as neurological examinations and sometimes a biopsy to determine the tumor's type and grade.

Treatment options for brain tumors depend on various factors, including the type, location, size, and grade of the tumor, as well as the patient's overall health. Treatment may include surgery to remove the tumor, radiation therapy, chemotherapy, targeted therapies, immunotherapy, and supportive care. The treatment and management of brain tumors are highly individualized, and a team of medical professionals, including neurologists, neurosurgeons, oncologists, and radiation oncologists, work together to provide the best possible care for patients with brain tumors.

The prognosis for humans with brain tumors varies widely and depends on factors like the tumor's type, grade, and stage, as well as the effectiveness of treatment and the patient's overall health. Some brain tumors can be cured, while others may require ongoing management until expiration of the human.

As stated above, brain tumors can be classified into various types based on their origin, behavior (benign or malignant), and the specific cells or tissues from which they develop.

Primary brain tumors originate in the brain itself. 

• Gliomas: These are the most common type of primary brain tumor and originate from glial cells, which support and protect nerve cells. They include: astrocytomas, which arise from astrocytes, star-shaped glial cells. They can be low-grade (slow-growing) or high-grade (fast-growing).
• Oligodendrogliomas: Developing from oligodendrocytes, these tumors are typically slow-growing.
• Ependymomas: Arising from ependymal cells lining the fluid-filled spaces in the brain and spinal cord.
• Mixed Gliomas: Tumors containing more than one type of glial cell.
• Meningiomas: These tumors originate from the meninges, the membranes that cover the brain and spinal cord. Meningiomas are often benign and slow-growing.
• Schwannomas (Vestibular Schwannomas): These tumors develop from Schwann cells, which surround and protect nerve cells. They usually occur on the cranial nerve that controls hearing and balance (vestibulocochlear nerve).

Secondary Brain Tumors, also known as metastatic brain tumors originate in other parts of the body (such as the lung, breast, or skin) and spread (metastasize) to the brain. Metastatic brain tumors are more common than primary brain tumors.

• Pituitary Tumors: These tumors develop in the pituitary gland, which is located at the base of the brain and regulates hormone production. Most pituitary tumors are benign.
• Pineal Region Tumors: These tumors occur in or around the pineal gland, which is located deep within the brain. Pineal region tumors can include pineocytomas, pineoblastomas, and germ cell tumors.
• Medulloblastomas: These tumors are a type of primitive neuroectodermal tumor (PNET) and mainly affect children. They develop in the cerebellum, the part of the brain responsible for balance and coordination.
• Craniopharyngiomas: These tumors develop near the pituitary gland and are most often benign. However, they can cause significant symptoms due to their location.
• Chordomas: Chordomas are rare tumors that usually occur at the base of the skull or along the spine.
• Hemangioblastomas: These tumors are typically benign and arise from blood vessel cells. They often occur in the cerebellum.
• Pineal Parenchymal Tumors: These tumors develop in the pineal gland and can be either pineal parenchymal tumor of intermediate differentiation (PPTID) or pineal parenchymal tumor of a high-grade histology (PPT-HGH).
• Primary Central Nervous System Lymphomas (PCNSL): These are non-Hodgkin lymphomas that originate in the brain, spinal cord, or eyes.

Brain Tumor Psychosis

Interestingly, brain tumors can potentially cause psychosis or psychotic symptoms in humans. The likelihood of psychosis caused by tumors depend on the location, size, and type of tumor. Psychosis refers to a set of symptoms that can include hallucinations (seeing or hearing things that are not there) and delusions (strongly held false beliefs). When a brain tumor affects certain areas of the brain responsible for perception, cognition, or emotional regulation, it can disrupt normal brain function and lead to psychosis. Some factors that contribute to the development of psychosis in individuals with brain tumors include:

• Location of the Tumor: Brain tumors located in specific areas of the brain, such as the frontal lobe or temporal lobe, are more likely to impact cognitive and emotional functions, potentially leading to psychotic symptoms.
• Pressure on Brain Tissue: As a brain tumor grows, it can exert pressure on surrounding brain tissue, causing damage and dysfunction. This pressure can disrupt normal brain circuits and contribute to symptoms of psychosis.
• Chemical Imbalances: Brain tumors can affect the balance of neurotransmitters (chemical messengers in the brain) and lead to changes in mood and perception, which may result in psychosis.
• Paraneoplastic Syndrome: In some cases, tumors can trigger an immune response that affects the brain and nervous system, leading to psychiatric symptoms, including psychosis.
• Treatments for brain tumors, such as surgery, radiation therapy, and chemotherapy, can also lead to neurological and psychiatric symptoms, including psychosis.

Humans who experience psychiatric symptoms, including psychosis, should seek medical attention promptly. Diagnosing and treating the underlying cause, such as a brain tumor, is crucial for managing and improving the patient's condition. Physicians may use a combination of imaging tests (e.g., MRI or CT scans), neurological assessments, and other diagnostic tools to identify and evaluate the tumor.

Treatment options for brain tumors and associated psychotic symptoms may include surgery, radiation therapy, chemotherapy, and medications to manage psychiatric symptoms. The specific treatment approach will depend on the tumor's type, location, size, and other individual factors. Early diagnosis and intervention can improve the prognosis and quality of life for individuals with brain tumors and associated psychiatric symptoms.

Causes of Brain Cancer

The exact causes of brain cancer are not fully understood by humans in 2023. In many cases, the specific cause remains unknown. Brain cancer, also known as malignant brain tumors, can result from various genetic, environmental, and lifestyle factors, but the precise factors that lead to the development of brain tumors vary from human to human. Here are some factors that may play a role in the development of brain cancer:

• Genetic Factors: Some individuals may have a genetic predisposition to certain types of brain tumors. Certain inherited genetic mutations, such as those associated with neurofibromatosis, Li-Fraumeni syndrome, and tuberous sclerosis, can increase the risk of brain cancer.
• Radiation Exposure: Exposure to ionizing radiation, such as high-dose radiation therapy used to treat other cancers or radiation from nuclear accidents, may increase the risk of brain cancer. However, this is a relatively rare cause of brain cancer.
• Chemical Exposure: Occupational exposure to certain chemicals, such as certain pesticides and industrial chemicals, has been investigated as a potential risk factor for brain cancer. However, the evidence linking specific chemicals to brain cancer is limited and inconclusive.
• Family History: While most brain cancers are not inherited, there may be some familial clustering of brain tumors in certain families. A family history of brain cancer may indicate a genetic predisposition, but it is not a common cause of the disease.
• Viral Infections: Some studies have suggested a possible association between viral infections, such as the Epstein-Barr virus (EBV) and cytomegalovirus (CMV), and an increased risk of certain brain cancers, particularly in individuals with weakened immune systems.
• Age and Gender: Brain cancer can occur at any age, but it is more commonly diagnosed in older adults. Gender can also play a role, as some types of brain tumors are more prevalent in one gender over the other.
• Race and Ethnicity: Certain racial and ethnic groups may have a higher or lower incidence of specific types of brain tumors. However, the reasons for these differences are not entirely understood and may involve a combination of genetic and environmental factors. Caucasians have slightly higher rates of brain cancer, particularly glioblastoma multiforme (GBM) than Asians and Africans. However, African American women tend to have higher rates of meningiomas. These are observations of general trends and do not apply to every individual within a racial or ethnic group. Furthermore, many factors, including genetic, environmental, and lifestyle factors, can influence cancer risk, and these factors can vary widely among individuals within the same racial or ethnic group.

Research into the causes and risk factors of brain cancer continues, and it's important to consider the complexity of the disease. Brain cancer is a complex disease, and for the vast majority of cases, the exact cause remains unclear. Furthermore, many people with one or more risk factors do not develop brain cancer, and many individuals without obvious risk factors can be diagnosed with brain tumors.

Research into the causes and risk factors of brain cancer continues, and advancements in understanding the disease may lead to improved prevention and treatment strategies in the future. If you have concerns about your risk of brain cancer or any symptoms that are of concern, it is advisable to consult with a healthcare professional for proper evaluation and guidance.

Recent Advances in the Fight Against Cancer

Biotechnology and medical research have led to numerous recent advances in the fight against cancer. These innovations encompass a wide range of approaches, including early detection, personalized treatment, immunotherapy, targeted therapies, and precision medicine. Here are some notable recent advances in the field of cancer research and treatment:

• Immunotherapy. Chimeric Antigen Receptor T-cell (CAR-T) therapy has shown remarkable success in treating certain blood cancers, such as leukemia and lymphoma. It involves genetically modifying a patient's own immune cells to target and destroy cancer cells. Immune checkpoint inhibitors, such as pembrolizumab and nivolumab, have been approved for a wide range of cancers. These drugs block inhibitory signals that prevent immune cells from attacking cancer cells, allowing the immune system to better recognize and fight cancer.
• Genomics. Advances in genomics and molecular profiling have enabled the identification of specific genetic mutations and alterations driving cancer growth. Targeted therapies are designed to inhibit these specific molecular targets, leading to more effective and less toxic treatments.
• PARP Inhibitors: Poly (ADP-ribose) polymerase (PARP) inhibitors have proven effective in treating breast, ovarian, and prostate cancers with specific DNA repair deficiencies, such as BRCA mutations.
• Early Detection and Screening:Advances in radiology, such as 3D mammography (tomosynthesis), have improved the accuracy of breast cancer screening. Liquid biopsy techniques allow for the detection of cancer-related genetic mutations and biomarkers through a simple blood test. This technology can aid in early cancer detection, monitoring treatment response, and assessing minimal residual disease. Stool DNA testing and virtual colonoscopy offer less invasive alternatives to traditional colonoscopy for the detection of colon cancer.
• Vaccines: Therapeutic cancer vaccines, like sipuleucel-T for prostate cancer, stimulate the immune system to target cancer cells specifically. The development of preventive vaccines, such as the human papillomavirus (HPV) vaccine, has significantly reduced the risk of certain cancers.
• Nanotechnology: Nanoparticles and nanocarriers are being explored to deliver chemotherapy and other cancer therapies directly to tumor cells while minimizing damage to healthy tissues.
• Liquid Radiation:Targeted alpha-particle radiotherapy, such as lutetium-177 PSMA therapy for prostate cancer, delivers high-dose radiation precisely to cancer cells while sparing normal tissue.
• Artificial Intelligence (AI):AI algorithms are being used to analyze medical images, predict treatment responses, and assist in treatment planning, improving the efficiency and accuracy of cancer care.

AI and the Fight Against Cancer

Artificial intelligence (AI) is playing an increasingly significant role in the fight against cancer and in the search for cures and more effective treatments. AI technologies are being applied in various ways to assist researchers, clinicians, and healthcare professionals in cancer research, diagnosis, treatment planning, and drug discovery. 

• Early Detection and Diagnosis: AI-powered algorithms can analyze medical imaging data, such as mammograms, CT scans, and MRIs, with remarkable accuracy. These algorithms can assist radiologists and pathologists in detecting and diagnosing cancer at earlier stages, when treatment is often more effective.
• Image Analysis: AI can help in the precise analysis of medical images to identify and classify cancerous tissues. It can detect subtle changes and anomalies that might be missed by the human eye.
• Predictive Analytics: AI can analyze vast datasets of patient information, including medical histories, genetic profiles, and treatment outcomes, to identify patterns and predict disease risks. This can help in identifying individuals who may be at higher risk of developing cancer.
• Personalized Treatment: AI can aid in the development of personalized treatment plans based on a patient's unique genetic makeup and the specific characteristics of their cancer. This can lead to more targeted and effective therapies, minimizing side effects.
• Drug Discovery: AI-driven algorithms can accelerate the drug discovery process by analyzing vast amounts of biological and chemical data. This can help identify potential drug candidates and predict their effectiveness in treating specific types of cancer.
• Genomic Analysis: AI can analyze genomic data to identify mutations and genetic variations associated with cancer. This information can be used to develop targeted therapies and predict treatment responses.
• Clinical Decision Support: AI systems can assist oncologists in making treatment decisions by providing evidence-based recommendations, analyzing patient data, and suggesting the most suitable treatment options.
• Drug Repurposing: AI can identify existing drugs that may have potential for repurposing in cancer treatment. This approach can save time and resources in drug development.
• Patient Monitoring: AI-powered wearable devices and remote monitoring tools can track patient health and treatment responses in real time, allowing for proactive adjustments to treatment plans.
• Research Assistance: AI can assist researchers in sifting through vast amounts of scientific literature and research papers to identify relevant studies and insights, facilitating more rapid progress in cancer research.
• Clinical Trials: AI can help identify suitable candidates for clinical trials, potentially increasing the efficiency and success of these trials.

The integration of AI into cancer research and treatment is still in its early stages. The overall success of AI in the cancer field depends on the quality and quantity of data available for analysis, as well as improvements in machine learning. 

AI has the potential to significantly advance human understanding of cancer by "connecting dots" that humans may have been unable to connect so far. The prowess of AI is its ability to find the proverbial needle in the haystack. A solution may be there, but it may be too hard for humans to find it. AI can locate in milliseconds a hidden needle in a haystack that would take humans significantly more time or or luck to find. 

AI promises to help human physicians and researchers improve early detection of cancer and enhancing treatment outcomes. By analyzing big data sets of biological interactions, AI will most likely be able to identify new biomarkers leading to early detection of precursors to tumor formation. By identifying patterns in big data sets of treatment options and outcomes, AI will most likely identify ways to improve the efficiency of existing treatments and facilitate the development of new therapies. In the pharmaceutical industry, AI will most likely contribute to analytical simulations that will lead to the identification of molecules and compounds that can aid in the treatment and possibly cure of many cancers.  

As with everything having to do with AI, humans are just beginning to experience the benefits and realizing the promises of computerized human-like intelligence assistance. The best is yet to come for humanity and for AI.

Stay tuned. 

Creatix.one, AI for everyone